SourceOne Stock Info  Your one source site for stock research

 

 

 

Company Website

Investor Relations

 

 

What’s the buzz—

message boards

Yahoo

Market Watch

Money Central

Raging Bull

Board Central

 

 

 

 

 

 

 

 

Cephalon, Inc.

 

CEPH

Cephalon, Inc. is an international biopharmaceutical company involved in the research, development and marketing of products to treat human diseases. The Company focuses its efforts in four core therapeutic areas: central nervous system disorders, pain, cancer and addiction. In addition to conducting an active research and development program, the company markets six products in the United States and number of products in countries throughout Europe. The Company’s main product is PROVIGIL (modafinil) Tablets (C-IV), which composed approximately 43% of its total consolidated net sales during the year ended December 2006, of which approximately 94% was in the United States market. Its product, ACTIQ (oral transmucosal fentanyl citrate) (C-II), accounted for about 34% of its total consolidated net sales during 2006, of which approximately 95% was in the United States.

 

Stock Quotes and Other Information

Nasdaq

NYSE

Msn

Yahoo

Silicon Investor

Excite

Lycos

Market Watch

Clear Station

StockHouse

 

SourceOne Message Board

 

Search for Stocks:

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Alphabetical Listings by Company Name

 

 

 

 

 

 

 

 

 

 

 

 

 

 

S&P 100     S&P 500     S&P 400     Dow Jones Industrials     Dow Jones Transportation     Dow Jones Utilities     Dow Jones Composite     Nasdaq 100     Morgan Stanley Hi-Tech 35

 

Home